Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that ...
Cancer patients receiving CAR T-cell therapy may develop and adverse event known as immune effector cell-associated neurotoxicity syndrome (ICANS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results